Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Cyclosporine A for Corneal Graft Rejection
NCT01028443Phase 4Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cyclosporine in graft rejection, sponsored by Shahid Beheshti University of Medical Sciences. Status: completed.
02
Drugs
cyclosporine
03
Conditions
graft rejection
Beyond the preview
Go deeper on NCT01028443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01028443.